Gastrodin alleviates angiotensin Ⅱ-induced hypertension and myocardial
apoptosis and PRDX2/p53 pathway activation
Abstract
Gastrodin is one of the foremost effective components of traditional
Chinese medicine Gastrodia elata Bl., which has been widely used
for anti-hypertension in China. However, the protection from myocardial
apoptosis in hypertension of gastrodin has not been systematic studied.
Our current study investigated the therapeutic effects and underlying
mechanisms of gastrodin on cardiac protection in hypertensive mice.
Treatment of gastrodin in Ang II-infused C57BL/6 mice significantly
alleviated the increase of blood pressure, cardiac dysfunction, heart
tibial ratio, and cardiac pathological changes. Kyoto Encyclopedia of
Genes and Genomes pathway analyses applied in the data of RNA-sequencing
by gastrodin treatment identified 697 up-regulated transcripts and 714
down-regulated transcripts, as well as 1105 enriched signaling pathways,
which also revealed that apoptosis and PRDX2/p53 pathway were involved
in the cardiac protection role of gastrodin. Consistently, gastrodin
treatment significantly reduced the cell apoptosis in cardiac tissues of
Ang II-infused mice and Ang II-stimulated H9c2 cells. In addition,
gastrodin treatment significantly also decreased the Bax/Bcl-2 ratio on
protein level, and down-regulated the protein levels of
cleaved-caspase3, cleaved-caspase9, PRDX2 and p53 in both cardiac
tissues and H9c2 cells stimulated with Ang II. In conclusion, gastrodin
treatment exhibits cardiac protection by reducing myocardial apoptosis
and suppressing PRDX2/p53 pathway activation in vitro and in
vivo.